MY131278A - Octahydrobenzo [g] quinoline - Google Patents

Octahydrobenzo [g] quinoline

Info

Publication number
MY131278A
MY131278A MYPI92000725A MYPI9200725A MY131278A MY 131278 A MY131278 A MY 131278A MY PI92000725 A MYPI92000725 A MY PI92000725A MY PI9200725 A MYPI9200725 A MY PI9200725A MY 131278 A MY131278 A MY 131278A
Authority
MY
Malaysia
Prior art keywords
octahydrobenzo
quinoline
medicament
compound
formula
Prior art date
Application number
MYPI92000725A
Inventor
Gull Dr Peter
Markstein Dr Rudolf
Original Assignee
Sandoz Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ltd filed Critical Sandoz Ltd
Publication of MY131278A publication Critical patent/MY131278A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Ophthalmology & Optometry (AREA)
  • Addiction (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

THE INVENTION RELATES TO THE COMPOUND OF FORMULA 1 IN FREE BASE FORM OR IN ACID ADDITION SALT FORM, ITS PREPARATION AND USE AS A MEDICAMENT.
MYPI92000725A 1991-05-02 1992-04-28 Octahydrobenzo [g] quinoline MY131278A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4114325A DE4114325A1 (en) 1991-05-02 1991-05-02 OCTAHYDROBENZO (G) QUINOLINE, ITS PRODUCTION AND USE

Publications (1)

Publication Number Publication Date
MY131278A true MY131278A (en) 2007-07-31

Family

ID=6430818

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI92000725A MY131278A (en) 1991-05-02 1992-04-28 Octahydrobenzo [g] quinoline

Country Status (18)

Country Link
EP (1) EP0512952A1 (en)
JP (1) JPH05170762A (en)
KR (1) KR920021533A (en)
AU (1) AU656768B2 (en)
CA (1) CA2067648A1 (en)
CS (1) CS131192A3 (en)
DE (1) DE4114325A1 (en)
FI (1) FI921957A (en)
HU (1) HUT61011A (en)
IE (1) IE921374A1 (en)
IL (1) IL101735A0 (en)
MX (1) MX9202024A (en)
MY (1) MY131278A (en)
NO (1) NO921723L (en)
NZ (1) NZ242562A (en)
RO (1) RO109333B1 (en)
TW (1) TW241262B (en)
ZA (1) ZA923187B (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9326010D0 (en) * 1993-12-21 1994-02-23 Sandoz Ltd Improvements in or relating to organic compounds
TW378209B (en) * 1996-07-08 2000-01-01 Novartis Ag Benzo[g]quinoline derivatives, their preparation and the pharmaceutical composition containing them
SE0001438D0 (en) 2000-04-18 2000-04-18 Axon Chemicals Bv New chemical compounds and their use in therapy
PE20030240A1 (en) * 2001-07-09 2003-04-16 Novartis Ag BENZO DERIVATIVES [g] QUINOLINE

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0077754B1 (en) * 1981-10-16 1990-09-26 Sandoz Ag Novel pharmaceutically active 1,2,3,4,4a,5,10,10a-octahydrobenzo(g)quinoline derivatives
PH22782A (en) * 1983-02-01 1988-12-12 Sandoz Ltd Novel pharmaceutical active 1,2,3,4,4a,5,10,10a octahydrobenzo(g)quinoline derivatives

Also Published As

Publication number Publication date
HUT61011A (en) 1992-11-30
TW241262B (en) 1995-02-21
ZA923187B (en) 1993-11-01
CA2067648A1 (en) 1992-11-03
AU1529192A (en) 1992-11-05
KR920021533A (en) 1992-12-18
DE4114325A1 (en) 1992-11-05
MX9202024A (en) 1992-11-01
IE921374A1 (en) 1992-11-04
IL101735A0 (en) 1992-12-30
HU9201296D0 (en) 1992-07-28
FI921957A (en) 1992-11-03
EP0512952A1 (en) 1992-11-11
AU656768B2 (en) 1995-02-16
NO921723L (en) 1992-11-03
FI921957A0 (en) 1992-04-30
NO921723D0 (en) 1992-04-30
RO109333B1 (en) 1995-01-30
CS131192A3 (en) 1992-11-18
NZ242562A (en) 1994-08-26
JPH05170762A (en) 1993-07-09

Similar Documents

Publication Publication Date Title
NZ240230A (en) Mercaptoacetylamide derivatives; preparation, use and pharmaceutical compositions thereof
CA2033392A1 (en) A-nor-steroid-3-carboxylic acid derivatives
EP0423714A3 (en) Hair revitalizing agent
MY104926A (en) Quinoline, quinazoline and cinnoline derivatives
MY133112A (en) 3-amino-3-arylpropan-1-ol derivatives, and their preparation and use
PT83104B (en) Novel guanidinomethylbenzoic acid derivatives
ES8704932A1 (en) Quinolonecarboxylic acid derivatives.
MD502G2 (en) New adenozine derivatives, methods of obtainitg thereof, farmaceutical compositions on the base thereof
MD1560G2 (en) Cyclic compounds, pharmaceutical compositions on base thereof and methods of treatment of infections or diseases provoked by retroviruses
NZ234501A (en) Hemoregulatory peptides and pharmaceutical compositions containing them
IL110460A0 (en) Bis-naphthalimides and pharmaceutical compositions containing them
GR3007401T3 (en)
CA2020474A1 (en) Antiinflammatory and/or antiallergic composition
MY131278A (en) Octahydrobenzo [g] quinoline
ES2005042A6 (en) Anticonvulsant composition containing amino acid derivative and use of said amino acid derivative.
GR3007219T3 (en)
ES2000681A6 (en) Benzylpiperazine compound, preparation thereof, pharmaceutical composition, and use.
IL103417A (en) Alkyl 5- 2-(2, 5-dialkoxyphenyl) ethyl9-2-hydroxybenzoates their preparation and pharmaceutical compositions containing them
KR960014780B1 (en) Dental plaque inhibitor composition and its preparation
BG103779A (en) Crystallohydrate sodium salt of (e)-4,6-dichloro-3-(2-oxo-1-phenylpyrrolidine-3-ilidenmethyl)-1h-i ndole-2-carboxylic acid
ES8801267A1 (en) 4H-pyrimido[2,1-a]isoquinolin-4-one derivatives.
NZ240695A (en) Stabilised aqueous antiseptic compositions containing 5-aminohexahydropyrimidine derivatives
ES8302719A1 (en) New cephem compounds, processes for preparation thereof and pharmaceutical composition comprising the same.
ES8400397A1 (en) New peptide, process for preparation thereof and use thereof.
AP9400608A0 (en) "New nicotinic acid derivative".